{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:21:22Z","timestamp":1789978882408,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovacion","doi-asserted-by":"crossref","award":["SAF2014-51991"],"award-info":[{"award-number":["SAF2014-51991"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["681002"],"award-info":[{"award-number":["681002"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human fibroblasts can be reprogrammed into induced hepatocyte-like cells through the expression of a set of transcription factors. Although the generation of induced hepatocyte-like cells by HNF4A, HNF1A, and FOXA3 expression has proven to be a robust experimental strategy, using multiple lentivirus results in a highly variable heterogeneous population.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We designed and implemented a novel approach based on the delivery of reprogramming factors and green fluorescent protein in a single doxycycline-inducible lentiviral vector using 2A self-cleaving peptides.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fibroblasts infected with the lentiviral vector can be amplified in basic fibroblast culture media in the absence of doxycycline without induction of hepatic genes. Upon switching to hepatic maturation media containing doxycycline, cells stop proliferating, activate hepatic gene transcription, and perform metabolic functions characteristic of hepatocytes.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our strategy can generate an unlimited source of homogeneously induced hepatocyte-like cells from different genetic background donors, capable of performing typical hepatic functions suitable for drug research and other in vitro applications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-019-1416-5","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T14:03:24Z","timestamp":1572876204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector"],"prefix":"10.1186","volume":"10","author":[{"given":"Maria","family":"Ballester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bolonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ribes-Koninckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-0536","authenticated-orcid":false,"given":"Roque","family":"Bort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/ajt.13678","volume":"16","author":"A Collin de l\u2019Hortet","year":"2016","unstructured":"Collin de l\u2019Hortet A, Takeishi K, Guzman-Lepe J, Handa K, Matsubara K, Fukumitsu K, et al. Liver-regenerative transplantation: regrow and reset. Am J Transplant. 2016;16:1688\u201396.","journal-title":"Am J Transplant"},{"key":"1416_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/clpt.2011.38","volume":"89","author":"H Inoue","year":"2011","unstructured":"Inoue H, Yamanaka S. The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther. 2011;89:655\u201361.","journal-title":"Clin Pharmacol Ther"},{"key":"1416_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.stem.2014.01.008","volume":"14","author":"Y Du","year":"2014","unstructured":"Du Y, Wang J, Jia J, Song N, Xiang C, Xu J, et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell. 2014;14:394\u2013403.","journal-title":"Cell Stem Cell"},{"key":"1416_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell. 2014;14:370\u201384.","journal-title":"Cell Stem Cell"},{"key":"1416_CR5","doi-asserted-by":"publisher","first-page":"e100134","DOI":"10.1371\/journal.pone.0100134","volume":"9","author":"KP Simeonov","year":"2014","unstructured":"Simeonov KP, Uppal H. Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. PLoS One. 2014;9:e100134.","journal-title":"PLoS One"},{"key":"1416_CR6","doi-asserted-by":"publisher","first-page":"16675","DOI":"10.1038\/s41598-017-16856-7","volume":"7","author":"D Nakamori","year":"2017","unstructured":"Nakamori D, Akamine H, Takayama K, Sakurai F, Mizuguchi H. Direct conversion of human fibroblasts into hepatocyte-like cells by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction. Sci Rep. 2017;7:16675.","journal-title":"Sci Rep"},{"key":"1416_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.stem.2011.11.003","volume":"9","author":"BW Carey","year":"2011","unstructured":"Carey BW, Markoulaki S, Hanna JH, Faddah DA, Buganim Y, Kim J, et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell. 2011;9:588\u201398.","journal-title":"Cell Stem Cell"},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2013.03.013","volume":"145","author":"A Holczbauer","year":"2013","unstructured":"Holczbauer A, Factor VM, Andersen JB, Marquardt JU, Kleiner DE, Raggi C, et al. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology. 2013;145:221\u201331.","journal-title":"Gastroenterology."},{"key":"1416_CR9","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1038\/srep03474","volume":"3","author":"YP Kong","year":"2013","unstructured":"Kong YP, Carrion B, Singh RK, Putnam AJ. Matrix identity and tractional forces influence indirect cardiac reprogramming. Sci Rep. 2013;3:3474.","journal-title":"Sci Rep"},{"key":"1416_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.stem.2008.08.014","volume":"3","author":"D Hockemeyer","year":"2008","unstructured":"Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell. 2008;3:346\u201353.","journal-title":"Cell Stem Cell"},{"key":"1416_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.stem.2007.10.002","volume":"2","author":"BE Welm","year":"2008","unstructured":"Welm BE, Dijkgraaf GJP, Bledau AS, Welm AL, Werb Z. Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell. 2008;2:90\u2013102.","journal-title":"Cell Stem Cell"},{"key":"1416_CR12","doi-asserted-by":"publisher","first-page":"L13","DOI":"10.1016\/j.bpj.2010.04.025","volume":"99","author":"KS Morozova","year":"2010","unstructured":"Morozova KS, Piatkevich KD, Gould TJ, Zhang J, Bewersdorf J, Verkhusha VV. Far-red fluorescent protein excitable with red lasers for flow cytometry and superresolution STED nanoscopy. Biophys J. 2010;99:L13\u20135.","journal-title":"Biophys J"},{"key":"1416_CR13","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1038\/onc.2014.240","volume":"34","author":"V Marfil","year":"2015","unstructured":"Marfil V, Blazquez M, Serrano F, Castell JV, Bort R. Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex. Oncogene. 2015;34:3011\u201322.","journal-title":"Oncogene."},{"key":"1416_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-016-0349-5","volume":"7","author":"F Serrano","year":"2016","unstructured":"Serrano F, Garc\u00eda-Bravo M, Blazquez M, Torres J, Castell JV, Segovia JC, et al. Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells. Stem Cell Res Ther. 2016;7:96.","journal-title":"Stem Cell Res Ther"},{"key":"1416_CR15","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.","journal-title":"Genome Biol"},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/toxsci\/kfw078","volume":"152","author":"L Tolosa","year":"2016","unstructured":"Tolosa L, G\u00f3mez-Lech\u00f3n MJ, L\u00f3pez S, Guzm\u00e1n C, Castell JV, Donato MT, et al. Human upcyte hepatocytes: characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing. Toxicol Sci Off J Soc Toxicol. 2016;152:214\u201329.","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"1416_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13287-015-0227-6","volume":"6","author":"L Tolosa","year":"2015","unstructured":"Tolosa L, Caron J, Hannoun Z, Antoni M, L\u00f3pez S, Burks D, et al. Transplantation of hESC-derived hepatocytes protects mice from liver injury. Stem Cell Res Ther. 2015;6:246.","journal-title":"Stem Cell Res Ther"},{"key":"1416_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1073\/pnas.0811426106","volume":"106","author":"BW Carey","year":"2009","unstructured":"Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A. 2009;106:157\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1416_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.stem.2008.02.001","volume":"2","author":"M Stadtfeld","year":"2008","unstructured":"Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell. 2008;2:230\u201340.","journal-title":"Cell Stem Cell"},{"key":"1416_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ng1175","volume":"34","author":"F Parviz","year":"2003","unstructured":"Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, et al. Hepatocyte nuclear factor 4\u03b1 controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003;34:292\u20136.","journal-title":"Nat Genet"},{"key":"1416_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nbt957","volume":"22","author":"AL Szymczak","year":"2004","unstructured":"Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, et al. Correction of multi-gene deficiency in vivo using a single \u201cself-cleaving\u201d 2A peptide\u2013based retroviral vector. Nat Biotechnol. 2004;22:589\u201394.","journal-title":"Nat Biotechnol"},{"key":"1416_CR22","doi-asserted-by":"publisher","first-page":"44385","DOI":"10.1074\/jbc.M108214200","volume":"276","author":"D Chaya","year":"2001","unstructured":"Chaya D, Hayamizu T, Bustin M, Zaret KS. Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin. J Biol Chem. 2001;276:44385\u20139.","journal-title":"J Biol Chem"},{"key":"1416_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1097-2765(00)80225-7","volume":"4","author":"LA Cirillo","year":"1999","unstructured":"Cirillo LA, Zaret KS. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol Cell. 1999;4:961\u20139.","journal-title":"Mol Cell"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1416-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1416-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1416-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:25:43Z","timestamp":1604363143000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1416-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1416-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}